Facility

Global Automation in Biopharma Market to Surge by 2031: Key Trends and Forecasts
Management & Regulatory Global Automation in Biopharma Market to Surge by 2031: Key Trends and Forecasts

Global Automation in Biopharma Market to Surge by 2031: Key Trends and Forecasts The global biopharma market is on the cusp of remarkable transformations driven by automation, enabling more efficient production processes and improved product quality. This evolving sector is undergoing significant

Rentschler Biopharma Expands U.S. Facility to Boost ATMP Production
Management & Regulatory Rentschler Biopharma Expands U.S. Facility to Boost ATMP Production

Rentschler Biopharma, a renowned contract development and manufacturing organization (CDMO), has recently made significant strides in expanding its facilities and operational capabilities. Located in Milford, Massachusetts, the new addition emphasizes the company's dedication to the burgeoning

Biopharma Surge: Facilities, Funding, Partnerships Propel Innovation
Management & Regulatory Biopharma Surge: Facilities, Funding, Partnerships Propel Innovation

The biopharmaceutical industry is in the midst of a significant surge, propelled by concerted expansion efforts, substantial financial investments, and strategic alliances. This dynamic landscape is marked by the growing demand for sophisticated therapeutics, which has led companies to bolster

Veranova Invests $30M in Devens Facility to Expand ADC Capabilities
Management & Regulatory Veranova Invests $30M in Devens Facility to Expand ADC Capabilities

In a significant move within the pharmaceutical manufacturing industry, Veranova has announced a substantial $30 million investment to enhance its Devens, Massachusetts facility. This strategic expansion is designed to bolster Veranova’s capabilities in developing and manufacturing antibody-drug

How Is SGD Pharma's China Upgrade Aiding Sustainability?
Management & Regulatory How Is SGD Pharma's China Upgrade Aiding Sustainability?

In a strategic move blending technological innovation with environmental consciousness, SGD Pharma has invested over €20 million to advance its facility in Zhanjiang, China. This significant refurbishment is not merely about upgrading the equipment but is part of a greener manifesto—committing to

NIBRT Opens €21M Biopharma Facility Boosting Ireland's Sector
Management & Regulatory NIBRT Opens €21M Biopharma Facility Boosting Ireland's Sector

The landscape of biopharmaceutical manufacturing in Ireland has recently welcomed an impressive addition with the inauguration of the National Institute for Bioprocessing Research and Training's (NIBRT) new facility. This state-of-the-art establishment in Dublin, conceived with a robust €21 million

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later